UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing*First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and ...

Today, the U.S. Food and Drug Administration conditionally approved Exzolt Cattle-CA1 (fluralaner) topical solution for the ...

UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK ...

The FDA has proposed adding bemotrizinol, a new sunscreen ingredient, to the U.S. approval list, which could expand consumer ...

Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...

Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its ...

A recent preemption decision out of the Southern District of New York offers encouraging news for medical device ...

The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...

FDA's new guidance clarifies promotional practices for biosimilars, ensuring accurate marketing and preventing misleading ...

Shares of CorMedix CRMD have witnessed a strong surge so far this year, primarily driven by the continued strong uptake of ...

“FDA is doing a thorough investigation, across multiple age groups, of deaths potentially related to coronavirus vaccines,” ...

The FDA declined to approve a targeted treatment for PDCD – sodium dichloroacetate (DCA) – in September 2025 despite encouraging clinical evidence and the voices of PDCD families reinforcing the ...